FDA warning : not to use PNC-27 products for treatment

By :

New Ebola Vaccine for Exposure Risk

Drug Information Center Consumers who use a contaminated product are at risk for serious, potentially life-threatening infections. Consumers at higher risk include vulnerable populations, such as young children, elderly people, pregnant women, and individuals with weakened immune systems. PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective to treat any disease, including any form of cancer. FDA recommends patients with cancer discuss treatment options with a licensed health care professional. Patients who have used any PNC-27 product and have concerns should contact their health care provider… View original post 73 more words
Rate UsDon’t love itNot greatGoodGreatLove itRate Us
Your opinion
arrow&v
arrow&v

PHAF Team

Using cosmetics during pregnancy may harm your child

PHAF Team

FDA approves first generic Crestor

PHAF Team

More than 300 fixed-dose combinations banned by Health Ministry (India)

PHAF Team

Vit. D overdose: lead to death of child

PHAF Team

FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease

PHAF Team

Small amount of chocolate each day may prevent diabetes

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.